XML 60 R15.htm IDEA: XBRL DOCUMENT
v3.20.1

Investments in Unconsolidated Entities | 3 Months Ended
--- | ---
Mar. 31, 2020
Equity Method Investments and Joint Ventures [Abstract] |
Investments in Unconsolidated Entities | Note 8 Investments in Unconsolidated Entities Investments in unconsolidated entities consist of amounts invested in entities in which U.S. Cellular holds a noncontrolling interest. U.S. Cellular’s Investments in unconsolidated entities are accounted for using either the equity method or measurement alternative method as shown in the table below. The carrying value of measurement alternative method investments represents cost minus any impairments plus or minus any observable price changes.
| March 31, 2020 |  | December 31, 2019
(Dollars in millions) |  |  |
Equity method investments | $ | 461 |  |  | $ | 440 |
Measurement alternative method investments | 8 |  |  | 7 |
Total investments in unconsolidated entities | $ | 469 |  |  | $ | 447 |
The following table, which is based on information provided in part by third parties, summarizes the combined results of operations of U.S. Cellular’s equity method investments.
| Three Months Ended March 31,
| 2020 |  | 2019
(Dollars in millions) |  |  |
Revenues | $ | 1,657 |  |  | $ | 1,689 |
Operating expenses | 1,162 |  |  | 1,215 |
Operating income | 495 |  |  | 474 |
Other income (expense), net | 3 |  |  | (5 | )
Net income | $ | 498 |  |  | $ | 469 |

X
- Definition The entire disclosure for cost method and equity method investments included basis, impairment losses, recognized or unrecognized gains (losses). + References No definition available. + Details
Name: | us-gaap_CostAndEquityMethodInvestmentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration